|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
45 Wiggins Ave, Bedford, Massachusetts 01730, US
|
|
Stoke Therapeutics is addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines. We develop antisense oligonucleotide medicines that increase gene expression to treat genetic epilepsies and other severe monogenic diseases, including genetic conditions affecting the central nervous system, eye, liver and kidney.
At Stoke, we believe our proprietary technology platform, Targeted Augmentation of Nuclear Gene Output, or #TANGO, will allow us to deliver disease-modifying therapies in a highly precise, durable and controlled manner. We have identified approximately 2,900 genetic diseases which we believe may be amenable to TANGO. At Stoke, we are united around a common goal: to improve the lives of people living with severe genetic diseases.
Stoke is located in Bedford, MA with offices in Cambridge, MA.
Connect with us at www.stoketherapeutics.com or on Twitter @StokeTX.
|
Stoke Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75%
|
The widely used Stoke Therapeutics email format is {f}{last} (e.g. [email protected]) with 75% adoption across the company.
To contact Stoke Therapeutics customer service number in your country click here to find.
Edward Kaye is the CEO of Stoke Therapeutics. To contact Edward Kaye email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.